logo
65 establishments get notices for not displaying nameplates in Marathi

65 establishments get notices for not displaying nameplates in Marathi

News1826-07-2025
Agency:
Palghar, Jul 26 (PTI) The district administration of Palghar in Maharashtra has issued notices to the owners of 65 commercial establishments for not displaying their nameplates in Marathi, officials said on Saturday.
The action was taken following reports that several hotels, shops and other establishments failing to comply with the rules.
A special campaign was launched at multiple locations across the district as per the directions of the Deputy Commissioner of Labour, a release said.
'Various teams carried out an operation to check the language used in the nameplates. The establishments that failed to display the nameplates in Marathi were identified," it said.
The enforcement teams then issued notices to 65 such establishments. These businesses were directed to immediately change the nameplates by adhering to the laid-down norms. Those who fail to comply will face legal action as per the provisions of the Act, the statement added.
Deputy Commissioner of Labour Vijay Chowdhary said the inspection drive will continue for the next few days, and urged all business owners across the district to ensure compliance.
Under Section 36(a)(1) of the Maharashtra Shops and Establishments (Regulation of Employment and Conditions of Service) Act, 2017, it is mandatory for all commercial establishments to display nameplates in Marathi language using the Devanagari script, he said. PTI COR NP
First Published:
July 26, 2025, 19:45 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump to impose new tariffs on pharmaceuticals in ‘next week or so' — ‘It is going to go to 250%'
Trump to impose new tariffs on pharmaceuticals in ‘next week or so' — ‘It is going to go to 250%'

Mint

time16 minutes ago

  • Mint

Trump to impose new tariffs on pharmaceuticals in ‘next week or so' — ‘It is going to go to 250%'

US President Donald Trump has announced that new US tariffs on semiconductor and pharmaceutical imports will be imposed 'within the next week or so.' The move is part of the administration's broader strategy to use trade levies to bring manufacturing back to the US and target key economic sectors, PTI reported. In a recent interview on CNBC, Trump outlined his tariff plan. 'We'll be putting an initially small tariff on pharmaceuticals, but in one year — one and a half years, maximum — it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country,' he said. The news report said this follows Trump's recent demand that major suppliers of medicines drastically cut costs or face additional, unspecified penalties. The world's largest drugmakers, including Merck & Co. and Eli Lilly & Co., operate scores of manufacturing sites across the globe. Nearly 90% of US biotech companies rely on imported components for at least half of their approved products, according to the Biotechnology Innovation Organization. In addition to imposing tariffs on pharmaceuticals, the president also revealed his plan to target the chip industry by stating, 'We're going to be announcing on semiconductors and chips, which is a separate category.' The Commerce Department has been investigating the semiconductor market since April to set the stage for possible tariffs on an industry that's expected to generate nearly $700 billion in global sales. These levies could lead to a sharp increase in costs for major data centre operators including Microsoft Corp, OpenAI, Meta Platforms Inc and Amazon that plan on investing billions of dollars in advanced semiconductors to propel their artificial intelligence businesses. Unlike some of the administration's previous country-specific tariffs, which have faced court challenges, these new sectoral tariffs have a stronger legal footing. These sectoral tariffs on pharmaceuticals, metals and other industries stem from trade investigations that can last about nine months and are based on national security groups under Section 232 of the Trade Expansion Act. Those so-called reciprocal tariffs are slated to go into effect on Thursday, PTI reported. The Trump administration has already used this authority to impose levies on imports of cars and auto parts as well as steel and aluminum.

Business outlook: Business confidence index jumps to 149.4 in April-June; NCAER survey flags optimism in sales
Business outlook: Business confidence index jumps to 149.4 in April-June; NCAER survey flags optimism in sales

Time of India

time26 minutes ago

  • Time of India

Business outlook: Business confidence index jumps to 149.4 in April-June; NCAER survey flags optimism in sales

India's business sentiment saw a sharp uptick in the April-June quarter, with the Business Confidence Index (BCI) rising to 149.4 from 139.3 in the previous quarter, according to the latest Business Expectations Survey by the National Council of Applied Economic Research (NCAER). The index is built on four key components: expectations of overall economic improvement over the next six months, anticipated improvement in firms' financial positions, views on the present investment climate, and whether capacity utilisation is close to or above optimal levels, PTI reported. NCAER noted that more than 60% of respondents expressed positive views across all four parameters. 'The share of positive responses remained above 60% for each component, and every component exhibited an improving trend compared to the previous quarter,' the think tank said. Optimism around production and domestic demand was particularly strong. Around 78.7% of firms said they expect production to rise in the next six months, while 79.1% anticipated an increase in domestic sales. Export sentiment also strengthened, with 66.5% of respondents expecting a rise in outbound shipments of finished goods. Firms were also more positive about their import requirements, with 54.3% expecting an increase in raw material imports, up from 46.1% in the previous quarter—a sign of expected acceleration in domestic manufacturing activity. Nearly 61% of companies surveyed expected pre-tax profits to rise over the next six months, indicating continued buoyancy in business operations. However, this optimism was not reflected in the labour market outlook. Hiring and wage expectations remained unchanged, suggesting a stagnation in employment sentiment. 'With moderation in costs, firms were more optimistic about the next six months,' said NCAER Professor Bornali Bhandari, who led the survey. The survey, conducted in June, covered 479 companies across six major Indian cities. Stay informed with the latest business news, updates on bank holidays and public holidays .

Lupin Q1 net profit jumps 52 pc to Rs 1,221 cr
Lupin Q1 net profit jumps 52 pc to Rs 1,221 cr

News18

time26 minutes ago

  • News18

Lupin Q1 net profit jumps 52 pc to Rs 1,221 cr

Agency: PTI Last Updated: New Delhi, Aug 5 (PTI) Drug maker Lupin on Tuesday posted a 52 per cent year-on-year increase in consolidated profit after tax at Rs 1,221 crore in the June quarter, driven by strong sales in the US and India. The drug maker reported a profit after tax (PAT) of Rs 805 crore in the April-June quarter of last fiscal. Sales rose to Rs 6,164 crore in the first quarter as against Rs 5,514 crore in the year-ago period, Lupin Ltd said in a statement. 'We continue to build strong business momentum, anchored by a robust product portfolio, improved efficiencies, and effective use of assets and investments," Lupin MD Nilesh Gupta said. 'As we begin the year, our sharpened focus on compliance, innovation, and technology positions us to further unlock sustainable growth," he added. India sales for Q1 FY26 stood at Rs 2,089 crore, up 8 per cent from Rs 1,938 crore. PTI MSS HVA view comments First Published: August 05, 2025, 21:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store